Page 10 - CIRN Annual Report 2017-18

CIRN | 2018 ANNUAL REPORT

CLINICAL TRIALS NETWORK

WHAT IS CTN?

The Clinical Trials Network (CTN) The network primarily focuses on CTN is the only infectious
answers public health questions research questions that are specifi c disease related vaccine
about immunization and vaccines to Canada, capture the diversity clinical trial network in
by conducting randomized of the population, and can rapidly Canada.
controlled clinical trials. conduct clinical trials to address
emerging issues.

PUBLICATIONS/
STUDIES CO-INVESTIGATORS STUDY LOCATIONS PRESENTATIONS
11 36 19 4

The CTN expertly coordinated four study locations in three
different countries for ACHIV-Ebola.

WHAT’S NEXT?

Collaborating with national Currently conducting Starting a randomized controlled
partners on a clinical development research on immune trial to compare a 1-dose
plan for a new vaccine to prevent correlates and engaging vs 2-dose priming schedule
invasive Haemophilus infl uenzae affected communities to plan of 13-valent pneumococcal
type a (Hia) disease in Canadian studies. conjugate vaccine (PCV13) in
Indigenous communities. Canadian infants.